Novartis AG (NVS) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Novartis AG
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
75267
First IPO Date
November 07, 1996
Key Executives
| Name | Title | Pay | Year Born |
| Vasant Narasimhan | Chief Executive Officer | 9.38M | 1976 |
| Robert Kowalski | Chief People & Organization Officer | 2.38M | 1968 |
| Steffen Lang | President of Operations | 2.65M | 1967 |
| Karen L. Hale | Chief Legal & Compliance Officer | 2.65M | 1968 |
| Patrick Horber | President of International | 3.39M | 1970 |
| Mukul Mehta | Chief Financial Officer | 3.77M | 1973 |
| Victor Bulto | President of US | 4.14M | 1978 |
| Evan Beckman | Global Head of Translational Medicine at Novartis Institute for BioMedical Research | 0 | N/A |
| Paul Penepent | Head of Group Financial Reporting and Accounting | 0 | N/A |
| Sloan Simpson | Global Head of Investor Relations | 0 | N/A |
AD
Description
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
AD
